Literature DB >> 3371470

Pancreatic carcinoma and low serum testosterone; a correlation secondary to cancer cachexia?

B D Todd1.   

Abstract

Serum testosterone concentration (S(T)) and four nutritional parameters were measured in patients with pancreatic adenocarcinoma (19), other malignancy (17) and other non-malignant conditions (29). In females neither the diagnosis nor the nutritional parameters correlated with the S(T). In males significantly lower S(T) were found in those with malignant conditions. Also, in males poor nutritional status correlated significantly with low S(T). Those patients with pancreatic adenocarcinoma did not have significantly lower S(T) than those with other cancers. A covariate analysis of the results supports the conjecture that it is primarily the poor nutritional status of cancer patients which leads to depression of S(T). This study provides no evidence to support the existence of a direct relationship between pancreatic cancer and testosterone metabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371470

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  5 in total

Review 1.  A systematic review of opioid effects on the hypogonadal axis of cancer patients.

Authors:  Kerry McWilliams; Claribel Simmons; Barry J Laird; Marie T Fallon
Journal:  Support Care Cancer       Date:  2014-03-15       Impact factor: 3.603

Review 2.  The role of androgens and estrogens on healthy aging and longevity.

Authors:  Astrid M Horstman; E Lichar Dillon; Randall J Urban; Melinda Sheffield-Moore
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-26       Impact factor: 6.053

3.  NeoGemTax: gemcitabine and docetaxel as neoadjuvant treatment for locally advanced nonmetastasized pancreatic cancer.

Authors:  Klaus Sahora; Irene Kuehrer; Martin Schindl; Claus Koelblinger; Peter Goetzinger; Michael Gnant
Journal:  World J Surg       Date:  2011-07       Impact factor: 3.352

4.  Hypogonadism in male cancer patients.

Authors:  Basil O Burney; Jose M Garcia
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-04-20       Impact factor: 12.910

5.  Flutamide in unresectable pancreatic adenocarcinoma: a randomized, double-blind, placebo-controlled trial.

Authors:  Sanjay Singh Negi; Anil Agarwal; Adarsh Chaudhary
Journal:  Invest New Drugs       Date:  2006-05       Impact factor: 3.651

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.